Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

DEFUZIN-B CREAM

Approval Number

SIN15684P

Drug Name

DEFUZIN-B CREAM

Product Name

DEFUZIN-B CREAM

Approval Date

May 13, 2019

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CREAM

Route of Administration

TOPICAL

Medical Information

ATC Code

D07CC01

ATC Item Name

betamethasone and antibiotics

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

Ingredient Name

BETAMETHASONE-17- VALERATE 1.21mg/g EQV BETAMETHASONE (MICRONIZED)

Strength

1mg/g

Drug MonographEstradiol valerate

Ingredient Name

FUSIDIC ACID (MICRONIZED)

Strength

20.0mg/g

Drug MonographFusidic acid

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy